YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Investing.com -- Bavarian Nordic shares rose around 4% Thursday after the company raised its full-year 2026 guidance again, lifting its revenue and profitability outlook on stronger-than-expected sales in its Travel Health business. Before…
Bavarian Nordic A/S Revenue and EBITDA margin expectations increased, driven by stronger-than-expected Travel Health sales COPENHAGEN, Denmark, October 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced an upgrade to the financial g…
Bavarian Nordic A/S COPENHAGEN, Denmark, October 5, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amount…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 28, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amou…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 22, 2026 - Pursuant to Section 31 of the Danish Capital Markets Act, it is hereby announced that as of September 21, 2026, Bavarian Nordic's holding of treasury shares amounted to 3,965,41…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amou…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 14, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amou…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 7, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amoun…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) has received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilitie…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 285,900 as a consequence of employees' exercise of warrants.…
Bavarian Nordic stock has delivered a solid 36.1% return over the past three years, while a fresh intrinsic value estimate using a Discounted Cash Flow (DCF) approach indicates the shares trade at a sizeable discount to that model. At the…
Bavarian Nordic A/S COPENHAGEN, Denmark, August 25, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibil…
This article first appeared on GuruFocus. Revenue: DKK 3.1 billion for the first half of 2026, with Q2 revenue of DKK 2.034 billion. EBITDA Margin: 35% for the first half of 2026; 45% for Q2. Gross Margin: 61% for Q2, driven by favorable p…
* Bavarian Nordic A/S press release [https://seekingalpha.com/pr/20626415-bavarian-nordic-reports-strong-first-half-2026-results] (BVNKF [https://seekingalpha.com/symbol/BVNKF]): Q2 Revenue of DKK 2.03B (+23.0% Y/Y). * Travel Health revenu…
Bavarian Nordic A/S COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the second quarter and first half of 2026 and released its financial calenda…
Bavarian Nordic A/S Guidance upgrade reflects upper end of previous guided revenue range and an improved EBITDA margin COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced an upgrade of the Company's finan…
Bavarian Nordic A/S MVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virus Approval further strengthens MVA-BN's position in supporting global pu…
Bavarian Nordic A/S COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory Agency (Anvisa) fo…
Bavarian Nordic A/S COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on June 2, 2026, has now been completed, reaching an aggregate amount of…
Bavarian Nordic A/S COPENHAGEN, Denmark, July 6, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares for an amount up to DK…
Bavarian Nordic A/S COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares for an amount up to D…
Bavarian Nordic A/S COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Health Canada has approved VIMKUNYA® (recombinant, adsorbed) for immunization to prevent disease caused by chikungunya virus infe…
Bavarian Nordic A/S COPENHAGEN, Denmark, June 22, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares for an amount up to D…
Bavarian Nordic A/S COPENHAGEN, Denmark, June 15, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares for an amount up to D…
Bavarian Nordic A/S COPENHAGEN, Denmark, June 9, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a government contract valued over DKK 700 million to supply its MVA-BN® smallpox/mpox vaccine to an undisclosed country in…
Bavarian Nordic A/S COPENHAGEN, Denmark, June 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on June 2, 2026, under which the Company will repurchase shares for an amount up to DK…
Bavarian Nordic A/S COPENHAGEN, Denmark, June 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) today launches the third and final tranche of the planned buy-back program, under which the Company intends to repurchase own shares for up to DKK 500…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Recent performance snapshot Bavarian Nordic (CPSE:BAVA) has attract…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Cholera Vaccine Market size & share revenue was valued at approximately USD 312 Millio…
This article first appeared on GuruFocus. Release Date: May 13, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Bavarian Nordic AS (BVNKF) reported a strong start to…
Bavarian Nordic A/S COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibiliti…
Bavarian Nordic A/S COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2026. Revenue for the first three months was DKK 1,05…
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. How Bavarian Nordic stock has been performing Bavarian Nordic (CPSE:BAVA) has seen mixed share performance recently, wi…
Bavarian Nordic A/S Exercised options total USD 97 million, covering manufacturing of bulk vaccine and supply of freeze-dried vaccines. Company upgrades full-year financial guidance COPENHAGEN, Denmark, May 11, 2026 – Bavarian Nordic A/S (…
Bavarian Nordic A/S COPENHAGEN, Denmark, May 11, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on March 12, 2026, has now been completed, reaching an aggregate amount of…